ArticleBritish journal of haematology2026

Plasmacytic markers as immunotherapeutic targets for primary CD20-negative aggressive B-cell lymphomas.

Frank Neumann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.